Cargando…
Lighting the way to host-directed immunotherapeutics
Developing broad-spectrum, host-directed antiviral therapeutics can be adapted to combat emerging viruses. In this issue of Cell Chemical Biology, Maarifi and colleagues implement a Nano luciferase reporter-based protein complementation assay to screen for small molecules and identify Gilteritinib,...
Autores principales: | van Tol, Sarah, Hage, Adam, Rajsbaum, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548442/ https://www.ncbi.nlm.nih.gov/pubmed/35868235 http://dx.doi.org/10.1016/j.chembiol.2022.06.009 |
Ejemplares similares
-
Finding the way to Wilms tumor by comparing the primary and relapse tumor samples
por: Spreafico, Filippo, et al.
Publicado: (2022) -
TRIM Proteins in Host Defense and Viral Pathogenesis
por: Giraldo, Maria I., et al.
Publicado: (2020) -
The TRIMendous Role of TRIMs in Virus–Host Interactions
por: van Tol, Sarah, et al.
Publicado: (2017) -
Mapping Genome Variants Sheds Light on Genetic and Phenotypic Differentiation in Chinese
por: Guo, Li, et al.
Publicado: (2019) -
Host-Pathogen Interactions after Lung Transplant: Are Cystic Fibrosis Patients Unique?
por: Morrell, Eric D., et al.
Publicado: (2020)